Pioneering the Future of Health Transformation

Founded in 2023 and based at MRANTI Park, Bukit Jalil (Technology Park Malaysia), SCI Laboratories Sdn Bhd is driven by one mission — to transform how we understand and manage health through molecular science.

At SCI Laboratories, we believe that health transformation begins with prevention, not reaction. By harnessing the power of Next-Generation Sequencing (NGS) and epigenetic technologies, we help individuals and healthcare professionals uncover vital biological insights — such as biological age, organ-specific aging, early molecular signs of cancer — long before symptoms appear and enable personalized oncology genomic profiling.

Our screening and diagnostic solutions focus on three core areas:

We empower clinicians, hospitals, and wellness centres with accurate, science-backed data to make smarter health decisions — supporting healthy aging, disease prevention, and personalized care.

Our Vision: Transforming Health 

We envision a future where healthcare goes beyond treating disease — where everyone understands their body’s true biological state and takes proactive steps toward healthy aging and lifelong wellness.

Our goal is to make molecular insights as part of everyday health practice.

Through data-driven prevention and precision molecular science, we aim to help people age gracefully, live healthy, and thrive disease with vitality.

By bridging science and daily health, we are redefining what it means to stay well in the world with modern medicine.

Whyus copy11
Whyus copy11

Our Mission

Everything we do is guided by our commitment to empower healthier lives.
Anti age

Empowering Resilience Against Aging

We help people understand how their bodies are truly aging at the molecular level, enabling them to make informed choices that slow aging, prevent chronic diseases, and improve longevity.

Healthcare

Bringing Molecular Science to Healthcare

We integrate cutting-edge NGS and genomic technologies into daily and clinical practice, and personalized preventive programs tailored to each individual and enabling precision oncology and treatment options.

Body scan

Detecting Disease Early, When It Matters Most

Through our PanCED™ (Pan-Cancer Early Detection) and OncoSCI™ Inherit profiling services, can identify diseases earlier and probably at the most treatable stages — improving survival and reducing the burden of late-stage treatments.

Public health

Building Collaborative Health Ecosystems

We partner with clinics, hospitals, and wellness centres to bring molecular testing into everyday care, contributing to a more connected and modern healthcare ecosystem in Malaysia.

Our Philosophy: Knowledge is Power of Prevention 

Health isn’t just the absence of disease — it’s the presence of understanding and taken preventive action!

At SCI Laboratories, we believe that knowledge empowers people to take control of their health. Every test we design turns complex molecular data into clear, actionable insights that help individuals and professionals make confident health decisions.

We live by four guiding principles:

SCI Laboratories — shaping a healthier future, one molecule, one insight, one disease, one life at a time.

Hallmark of cancer
Hallmark of cancer

Advisory Board 

Dr Koh Chong Lek1

Scientific Advisor
Academician Dr. Koh Chong Lek, PhD, FASc 

Academician Dr Koh Chong Lek FASc, a multi-award winning scientist, is one of 30 Senior Fellows of the Academy of Sciences Malaysia. Since 1981, he has pioneered and provided dynamic leadership in the advancement of genetics, molecular biology, and biotechnology in Malaysia and the Asia-Pacific region. He has authored more than 100 scientific publications. Currently, as a Genetics, Aging, and Nutrigenomics consultant, he is actively promoting wellness and preventive healthcare to delay aging and extend healthspan.
Garylu 1

Medical Advisor Prof. Gary Lu, MD, ABMG 

Prof. Lu is a pioneer in cancer genetic counselling and oncologic genomic diagnostics, as well as hereditary cancer, with over 33 years of clinical experience in the United States. He was among the first cohort of Chinese scholars to obtain ABMG certification in 1996 and is a member of the ACMG Expert Committee. In 2008, he became the first ABMG-certified Director of Oncologic Cytogenomic Diagnostics at MD Anderson Cancer Center. Prof. Lu has authored more than 70 SCI- indexed oncology publications and served as editor-in-chief of three landmark medical genetics monographs in China. He is currently a Professor at Zujiang Hospital of Southern Medical University.